NewsBenzingaTeva Expands Samsung Bioepis Collaboration With ETICOVO, Infliximab-Abda Deal; Upfront Payment Over 3 Years, Launch And Sales Milestones Possible, Profits Shared Teva Expands Samsung Bioepis Collaboration With ETICOVO, Infliximab-Abda Deal; Upfront Payment Over 3 Years, Launch And Sales Milestones Possible, Profits Shared Benzinga 2026.11.03 10:04 (GMT+0) Open on Benzinga Other news Federal Realty Investment Trust Impresses In Q3 Results While Also Growing Portfolio (FRT) Bear Call Spread Ideas for Applovin Earnings What Are Wall Street Analysts' Target Price for Keurig Dr Pepper Stock? Nasdaq Futures Climb as Chip Stocks Rebound; U.S. Midterms in Focus Are Wall Street Analysts Bullish on QUALCOMM Stock? McDonald’s Is Beefing Up, but It Won’t Be Cheap
